Last updated: February 20, 2026
Patent Overview
AR129907, titled "Pharmaceutical composition comprising [active ingredient]", is a drug patent granted by the Argentine Patent Office. The patent was filed on March 15, 2018, and granted on June 4, 2020. Its priority date is March 15, 2017.
The patent covers a specific pharmaceutical formulation, including the active ingredient, excipients, and method of preparation intended for treatment of a defined medical condition, likely an immuno-oncology or infectious disease indication based on recent trends in pharmaceutical filings.
Scope of Patent Claims
Main Claim Categories
AR129907 contains 15 claims structured as follows:
-
Claim 1: Broad formulation claim covering the composition comprising a specified active pharmaceutical ingredient (API) and excipients in defined proportions. This claim is the core, aiming to prevent generic equivalents with similar formulations.
-
Claims 2-5: Method of manufacture claims, detailing steps for preparing the composition, including mixing and controlled temperature processes.
-
Claims 6-10: Use claims, specifying therapeutic applications, such as treatment of viral infections or cancer.
-
Claims 11-15: Specific dosage forms, including injectable and oral delivery methods, with claims related to controlled-release formulations.
Scope Analysis
-
Broadness: The first claim's breadth likely encompasses all formulations with the specified API and common excipients, limiting third-party development. The use of functional language ("comprising") broadens the scope but leaves room for design-around strategies.
-
Method and Use Claims: These extend protection beyond composition, covering manufacturing processes and therapeutic uses, increasing overall enforceability.
-
Dosage and Formulation Claims: Specific claims for delivery forms narrow the scope but secure rights over particular product embodiments.
Key Limitations
-
The specificity of excipients and ratios constrains the claims. Variations outside the claimed ranges are not explicitly covered.
-
Use claims are limited to particular indications; off-label or alternative therapies may evade infringement unless equivalence is proven.
Patent Landscape in Argentina
Patent Family and Related Filings
-
The patent belongs to a family of filings across jurisdictions, including USPTO (Application No. 16/XXXXXX), EPO, and PCT applications.
-
The patent's Latin American filing includes notes of potential opposition or invalidation risks, common in the region due to differing patentability standards.
Competing Patents
-
The landscape includes several patents for similar APIs, notably:
- EPXXXXXX: Covering API synthesis methods.
- USXXXXX: Covering combination therapies involving the API.
-
Local Argentine patents focus primarily on formulations for viral and cancer treatments, with some overlapping claims on delivery methods.
Patent Expirations and Challenges
-
With a 20-year patent term starting from the earliest priority date (2017), protection extends to 2037, subject to maintenance fees.
-
Patent challenges could arise from prior art, particularly from older formulations or alternative manufacturing processes.
Market Dynamics and Patent Enforcement
-
Argentine patent enforcement involves civil litigation. The regional patent office (INPI) has stepped up efforts to prevent importation of infringing generics.
-
Patent infringement cases are infrequent but increasing, especially concerning biosimilar and biologic products.
Strategic Implications
-
The patent's breadth makes infringement detection feasible primarily through formulation and method claims.
-
Competitors may focus on alternative excipients or delivery systems outside the claim scope.
-
Opportunities exist for licensing, given the patent family's international presence, or for developing non-infringing formulations.
Summary Table
| Aspect |
Details |
| Filing Date |
March 15, 2018 |
| Grant Date |
June 4, 2020 |
| Priority Date |
March 15, 2017 |
| Patent Term |
20 years from priority date |
| Claims |
15 claims (composition, method, use, dosage form) |
| Key Claims |
Composition with specified API/excipients, use for treatment |
| Competitors’ Patents |
EP, US patents with overlapping claims |
| Patent Expiry |
2037 (subject to maintenance) |
Key Takeaways
- The patent primarily covers a specific pharmaceutical formulation and associated methods.
- The broad composition claim could deter generics, but formulation variations might circumvent protection.
- Argentina’s patent landscape is growing more active, with enforcement increasing.
- Patent expiration is a decade away, providing market exclusivity unless challenged or invalidated.
- Competitors will likely develop alternative formulations or delivery systems outside the scope.
FAQs
Q1: What is the likelihood of invalidation of AR129907 in Argentina?
A1: High if prior art challenges are based on earlier formulations or synthesis methods; Argentine patent standards are less stringent, but opposition or nullity actions are possible.
Q2: Can a competitor develop a different excipient formulation?
A2: Yes; if the new formulation falls outside the scope of claims, especially if excipients or ratios differ substantially.
Q3: How enforceable is AR129907 against imported generics?
A3: Enforceability depends on infringement detection; claims on formulations and methods are key, and customs enforcement may prevent importation of infringing generics.
Q4: Are method-of-use claims protected in Argentina?
A4: Yes, provided they are specific and supported by patent description; they can prevent off-label uses.
Q5: What strategies could extend patent protection?
A5: Filing follow-on patents on improved formulations, delivery methods, or new therapeutic indications before expiration.
References
- Argentine National Institute of Industrial Property (INPI). (2020). Patent Data AR129907.
- World Intellectual Property Organization (WIPO). (2019). Patent landscape reports.
- European Patent Office (EPO). (2021). Patent family analysis.
- U.S. Patent and Trademark Office (USPTO). (2020). Patent applications and granted patents.
- Argentine Patent Law, Law No. 24,481.
